Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The purpose of this literature review was to determine the impact of vitamin D supplementation on BPD incidence among preterm infants born ≤36 weeks GA.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Publisher article type: review-article

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effect of vitamin D supplementation on incidence of bronchopulmonary dysplasia among preterm infants up to 36 weeks' gestational age

Review / evidence synthesis · Nutrition in Clinical Practice · 2025

Original publication title

Effect of vitamin D supplementation on incidence of bronchopulmonary dysplasia among preterm infants up to 36 weeks' gestational age

Tara Rebele; Corey Hawes; Stephani Johnson; Melanie Newkirk

© 2025 The Author(s). Nutrition in Clinical Practice published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Preterm infants, especially those born at a younger gestational age (GA), are at risk for developing bronchopulmonary dysplasia (BPD), which can lead to longer hospitalizations, chronic pulmonary morbidity, and mortality. Vitamin D plays a role in lung and immune system development, and deficiency at birth is associated with a greater incidence of BPD among preterm infants. The purpose of this literature review was to determine the impact of vitamin D supplementation on BPD incidence among preterm infants born ≤36 weeks GA.

A literature search of the PubMed, CINAHL, SCOPUS, and Google Scholar databases was conducted searching for clinical studies published since 2014 that evaluated the effect of vitamin D supplementation on BPD incidence among preterm infants ≤36 weeks GA. We identified and reviewed six clinical studies published between 2014 and 2023, including a total of 545 preterm infants born 25 to 34 weeks GA. Vitamin D supplementation between 800 to 1000 IU/day was safe and effective in significantly improving vitamin D status and significantly reducing vitamin D deficiency; however, positive findings regarding the influence of vitamin D supplementation in reducing the incidence of BPD were not consistent.

More research is needed in the form of well‐designed RCTs investigating the effect of vitamin D supplemented at 800 to 1000 IU compared with the standard 400 IU dose on the incidence of BPD as the primary outcome.

Authors’ abstract

Abstract

Preterm infants, especially those born at a younger gestational age (GA), are at risk for developing bronchopulmonary dysplasia (BPD), which can lead to longer hospitalizations, chronic pulmonary morbidity, and mortality. Vitamin D plays a role in lung and immune system development, and deficiency at birth is associated with a greater incidence of BPD among preterm infants. The purpose of this literature review was to determine the impact of vitamin D supplementation on BPD incidence among preterm infants born ≤36 weeks GA.

A literature search of the PubMed, CINAHL, SCOPUS, and Google Scholar databases was conducted searching for clinical studies published since 2014 that evaluated the effect of vitamin D supplementation on BPD incidence among preterm infants ≤36 weeks GA. We identified and reviewed six clinical studies published between 2014 and 2023, including a total of 545 preterm infants born 25 to 34 weeks GA. Vitamin D supplementation between 800 to 1000 IU/day was safe and effective in significantly improving vitamin D status and significantly reducing vitamin D deficiency; however, positive findings regarding the influence of vitamin D supplementation in reducing the incidence of BPD were not consistent.

More research is needed in the form of well‐designed RCTs investigating the effect of vitamin D supplemented at 800 to 1000 IU compared with the standard 400 IU dose on the incidence of BPD as the primary outcome.

Publication and source details

Original title: Effect of vitamin D supplementation on incidence of bronchopulmonary dysplasia among preterm infants up to 36 weeks' gestational age

Tara Rebele; Corey Hawes; Stephani Johnson; Melanie Newkirk

Nutrition in Clinical Practice · 2025

* Correspondence Tara Rebele, MPH, RDN, Department of Clinical and Preventive Nutrition Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
Email: tr494@shp.rutgers.edu
© 2025 The Author(s). Nutrition in Clinical Practice published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:39:50.609657+00:00

DOI: 10.1002/ncp.11323 · PMC12242094